---
document_datetime: 2024-09-02 11:12:06
document_pages: 26
document_pathfilename: www.ema.europa.eu/en/documents/procedural-steps-after/olanzapine-teva-epar-procedural-steps-taken-scientific-information-after-authorisation-archive_en.pdf
document_name: olanzapine-teva-epar-procedural-steps-taken-scientific-information-after-authorisation-archive_en.pdf
version: success
processing_time: 13.8400931
conversion_datetime: 2025-12-28 05:17:32.48712
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
## Olanzapine Teva

Procedural steps taken and scientific information after the authorisation

| Application number   | Scope                                                                                            | Opinion/ Notification 1 issued on   | Commission Decision Issued 2 / amended on   | Product Information affected 3   | Summary   |
|----------------------|--------------------------------------------------------------------------------------------------|-------------------------------------|---------------------------------------------|----------------------------------|-----------|
| N/0087               | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification) | 11/10/2021                          |                                             | PL                               |           |
| IA/0085/G            | This was an application for a group of variations.                                               | 03/03/2021                          | n/a                                         |                                  |           |

<!-- image -->

<!-- image -->

<div style=\"page-break-after: always\"></div>

|           | Eur. Certificate of Suitability to the relevant Ph. Eur. Monograph - Updated certificate from an already approved manufacturer B.III.1.a.2 - Submission of a new/updated or deletion of Ph. Eur. Certificate of Suitability to the relevant Ph. Eur. Monograph - Updated certificate from an already approved manufacturer   |            |            |                                  | deletion of Ph.   |
|-----------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|----------------------------------|-------------------|
| IA/0084   | A.7 - Administrative change - Deletion of manufacturing sites                                                                                                                                                                                                                                                                | 01/03/2021 |            | Annex II and PL                  |                   |
| IA/0083   | B.III.1.a.2 - Submission of a new/updated or deletion of Ph. Eur. Certificate of Suitability to the relevant Ph. Eur. Monograph - Updated certificate from an already approved manufacturer                                                                                                                                  | 14/01/2021 | n/a        |                                  |                   |
| IB/0082   | C.I.2.a - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessment of the same change for the reference product - Implementation of change(s) for which NO new additional data is required to be submitted by the MAH                                                                 | 28/04/2020 | 31/07/2020 | SmPC, Annex II, Labelling and PL |                   |
| IA/0081   | B.III.1.a.2 - Submission of a new/updated or deletion of Ph. Eur. Certificate of Suitability to the relevant Ph. Eur. Monograph - Updated certificate from an already approved manufacturer                                                                                                                                  | 12/12/2019 | n/a        |                                  |                   |
| IB/0080/G | This was an application for a group of variations. Change to in-process tests or limits                                                                                                                                                                                                                                      | 23/10/2019 | 31/07/2020 | SmPC and PL                      | B.II.b.5.z -      |

<div style=\"page-break-after: always\"></div>

|           | during the manufacture of the finished - Other variation - Change to in-process tests or limits during the manufacture of the finished - Other variation                                                                                                                                                                                                                                                              |            |            |                        | applied product B.II.b.5.z applied product   |
|-----------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|------------------------|----------------------------------------------|
| IB/0079   | C.I.2.a - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessment of the same change for the reference product - Implementation of change(s) for which NO new additional data is required to be submitted by the MAH                                                                                                                                                          | 23/07/2019 | 31/07/2020 | SmPC, Labelling and PL |                                              |
| N/0077    | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                                                                                                                                                                                                                                                                                      | 29/04/2019 | 31/07/2020 | Labelling and PL       |                                              |
| IB/0078/G | This was an application for a group of variations. B.I.d.1.a.4 - Stability of AS - Change in the re-test period/storage period - Extension or introduction of a re-test period/storage period supported by real time data B.III.1.a.2 - Submission of a new/updated or deletion of Ph. Eur. Certificate of Suitability to the relevant Ph. Eur. Monograph - Updated certificate from an already approved manufacturer | 25/04/2019 | n/a        |                        |                                              |
| IA/0076   | B.III.1.a.2 - Submission of a new/updated or deletion of Ph. Eur. Certificate of Suitability to the relevant Ph. Eur. Monograph - Updated certificate from an already approved manufacturer                                                                                                                                                                                                                           | 19/04/2018 | n/a        |                        |                                              |

<div style=\"page-break-after: always\"></div>

| N/0075      | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                                                                                                                                                                                                                                                                                     | 19/02/2018   | 31/07/2020   | PL          |              |
|-------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|--------------|-------------|--------------|
| N/0074      | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                                                                                                                                                                                                                                                                                     | 28/11/2017   | 19/02/2018   | PL          |              |
| IA/0073     | B.II.b.4.b - Change in the batch size (including batch size ranges) of the finished product - Downscaling down to 10-fold                                                                                                                                                                                                                                                                                            | 11/05/2017   | n/a          |             |              |
| IB/0072     | B.II.b.3.z - Change in the manufacturing process of the finished or intermediate product - Other variation                                                                                                                                                                                                                                                                                                           | 15/03/2017   | n/a          |             |              |
|             | C.I.z - Changes (Safety/Efficacy) of Human and Veterinary Medicinal Products - Other variation                                                                                                                                                                                                                                                                                                                       | 07/02/2017   | 19/02/2018   | SmPC and PL | IAIN/0071    |
| IA/0070     | B.II.b.3.a - Change in the manufacturing process of the finished or intermediate product - Minor change in the manufacturing process                                                                                                                                                                                                                                                                                 | 08/12/2016   | n/a          |             |              |
| IAIN/0069/G | This was an application for a group of variations. B.I.b.1.c - Change in the specification parameters and/or limits of an AS, starting material/intermediate/reagent - Addition of a new specification parameter to the specification with its corresponding test method B.III.1.a.3 - Submission of a new/updated or deletion of Ph. Eur. Certificate of Suitability to the Eur. Monograph - New certificate from a | 02/12/2016   | n/a          |             | relevant Ph. |

<div style=\"page-break-after: always\"></div>

|           | new manufacturer (replacement or addition)                                                                                                                                                                                                                                                                                                                                                                        |            |            |                        |
|-----------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|------------------------|
| IA/0068   | B.III.2.a.2 - Change of specification(s) of a former non EU Pharmacopoeial substance to fully comply with the Ph. Eur. or with a national pharmacopoeia of a Member State - Excipient/AS starting material                                                                                                                                                                                                        | 07/10/2016 | n/a        |                        |
| IAIN/0067 | C.I.z - Changes (Safety/Efficacy) of Human and Veterinary Medicinal Products - Other variation                                                                                                                                                                                                                                                                                                                    | 21/07/2016 | 21/10/2016 | SmPC, Labelling and PL |
| IA/0066   | B.III.1.a.2 - Submission of a new/updated or deletion of Ph. Eur. Certificate of Suitability to the relevant Ph. Eur. Monograph - Updated certificate from an already approved manufacturer                                                                                                                                                                                                                       | 15/06/2016 | n/a        |                        |
| IB/0064/G | This was an application for a group of variations. B.I.d.1.a.4 - Stability of AS - Change in the re-test period/storage period - Extension or introduction of a re-test period/storage period supported by real time data B.III.1.a.1 - Submission of a new/updated or deletion of Ph. Eur. Certificate of Suitability to the relevant Ph. Eur. Monograph - New certificate from an already approved manufacturer | 26/05/2016 | n/a        |                        |
| IA/0065/G | This was an application for a group of variations. A.5.b - Administrative change - Change in the name and/or address of a manufacturer/importer of the finished product, including quality control sites                                                                                                                                                                                                          | 18/03/2016 | 21/10/2016 | Annex II and PL        |

<div style=\"page-break-after: always\"></div>

|             | (excluding manufacturer for batch release) - Administrative change - Deletion of manufacturing sites                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |            |            |                        | A.7   |
|-------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|------------------------|-------|
| IAIN/0062/G | This was an application for a group of variations. B.II.e.5.a.1 - Change in pack size of the finished product - Change in the number of units (e.g. tablets, ampoules, etc.) in a pack - Change within the range of the currently approved pack sizes B.II.e.5.a.1 - Change in pack size of the finished product - Change in the number of units (e.g. tablets, ampoules, etc.) in a pack - Change within the range of the currently approved pack sizes B.II.e.5.a.1 - Change in pack size of the finished product - Change in the number of units (e.g. tablets, ampoules, etc.) in a pack - Change within the range of the currently approved pack sizes B.II.e.5.a.1 - Change in pack size of the finished product - Change in the number of units (e.g. tablets, ampoules, etc.) in a pack - Change within the range of the currently approved pack sizes B.II.e.5.a.1 - Change in pack size of the finished product - Change in the number of units (e.g. tablets, ampoules, etc.) in a pack - Change within the range of the currently approved pack sizes B.II.e.5.a.1 - Change in pack size of the finished product - Change in the number of units (e.g. tablets, ampoules, etc.) in a pack - Change within the range of the currently approved pack sizes | 11/11/2015 | 21/10/2016 | SmPC, Labelling and PL |       |

<div style=\"page-break-after: always\"></div>

| product - Change in the tablets, ampoules, etc.) the range of the currently B.II.e.5.a.1 - Change product - Change in the tablets, ampoules, etc.) the range of the currently B.II.e.5.a.1 - Change product - Change in the tablets, ampoules, etc.) the range of the currently B.II.e.5.a.1 - Change product - Change in the tablets, ampoules, etc.) the range of the currently B.II.e.5.a.1 - Change product - Change in the tablets, ampoules, etc.) the range of the currently B.II.e.5.a.1 - Change product - Change in the tablets, ampoules, etc.) the range of the currently B.II.e.5.a.1 - Change product - Change in the tablets, ampoules, etc.) the range of the currently B.II.e.5.a.1 - Change product - Change in the tablets, ampoules, etc.) the range of the currently   |
|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

<div style=\"page-break-after: always\"></div>

|             | product - Change in the number of units (e.g. tablets, ampoules, etc.) in a pack - Change within the range of the currently approved pack sizes B.II.e.5.a.1 - Change in pack size of the finished product - Change in the number of units (e.g. tablets, ampoules, etc.) in a pack - Change within the range of the currently approved pack sizes B.II.e.5.a.1 - Change in pack size of the finished product - Change in the number of units (e.g. tablets, ampoules, etc.) in a pack - Change within the range of the currently approved pack sizes B.II.e.5.a.1 - Change in pack size of the finished product - Change in the number of units (e.g. tablets, ampoules, etc.) in a pack - Change within the range of the currently approved pack sizes B.II.e.5.a.1 - Change in pack size of the finished product - Change in the number of units (e.g. tablets, ampoules, etc.) in a pack - Change within the range of the currently approved pack sizes B.II.e.5.a.1 - Change in pack size of the finished product - Change in the number of units (e.g. tablets, ampoules, etc.) in a pack - Change within the range of the currently approved pack sizes B.II.e.5.a.1 - Change in pack size of the finished product - Change in the number of units (e.g. tablets, ampoules, etc.) in a pack - Change within   |            |            |                        |
|-------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|------------------------|
| IAIN/0063/G | This was an application for a group of variations. B.II.c.3.z - Change in source of an excipient or                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  | 09/11/2015 | 21/10/2016 | SmPC, Labelling and PL |

<div style=\"page-break-after: always\"></div>

|           | Other variation B.II.e.5.a.1 - Change in pack size of the finished product - Change in the number of units (e.g. tablets, ampoules, etc.) in a pack - Change within the range of the currently approved pack sizes B.II.e.5.a.1 - Change in pack size of the finished product - Change in the number of units (e.g. tablets, ampoules, etc.) in a pack - Change within the range of the currently approved pack sizes   |            |            |                                  | reagent with TSE risk -   |
|-----------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|----------------------------------|---------------------------|
| IB/0061   | B.II.f.1.b.1 - Stability of FP - Extension of the shelf life of the finished product - As packaged for sale (supported by real time data)                                                                                                                                                                                                                                                                               | 05/10/2015 | 21/10/2016 | SmPC and PL                      |                           |
| IA/0060   | B.II.e.7.a - Change in supplier of packaging components or devices (when mentioned in the dossier) - Deletion of a supplier                                                                                                                                                                                                                                                                                             | 01/07/2015 | n/a        |                                  |                           |
| T/0059    | Transfer of Marketing Authorisation                                                                                                                                                                                                                                                                                                                                                                                     | 12/03/2015 | 09/04/2015 | SmPC, Labelling and PL           |                           |
| IB/0058   | B.II.e.1.z - Change in immediate packaging of the finished product - Other variation                                                                                                                                                                                                                                                                                                                                    | 27/01/2015 | 09/04/2015 | SmPC, Labelling and PL           |                           |
| II/0055/G | This was an application for a group of variations. A.5.b - Administrative change - Change in the name and/or address of a manufacturer/importer of the finished product, including quality control sites manufacturer for batch release)                                                                                                                                                                                | 22/01/2015 | 09/04/2015 | SmPC, Annex II, Labelling and PL | (excluding                |

<div style=\"page-break-after: always\"></div>

<!-- image -->

| A.7 - Administrative change manufacturing sites B.II.a.2.a - Change in the pharmaceutical form - Immediate capsules, suppositories and B.II.a.3.a.1 - Changes in (excipients) of the finished components of the flavouring Addition , deletion or replacement B.II.a.3.b.2 - Changes in (excipients) of the finished - Qualitative or quantitative excipients that may have safety, quality or efficacy B.II.b.1.a - Replacement manufacturing site for the site B.II.b.1.b - Replacement manufacturing site for the site B.II.b.1.e - Replacement manufacturing site for the manufacturing operation(s) release, batch control, primary packaging, for non-sterile B.II.b.2.a - Change to importer, arrangements and quality Replacement/addition of control/testing takes place B.II.b.2.c.1 - Change to arrangements and quality   |
|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

<div style=\"page-break-after: always\"></div>

<!-- image -->

| responsible for importation Not including batch control/testing B.II.b.2.c.2 - Change to arrangements and quality Including batch control/testing B.II.b.3.b - Change in the finished or intermediate changes to a manufacturing significant impact on the of the medicinal product B.II.b.4.a - Change in size ranges) of the finished compared to the originally B.II.d.1.c - Change in and/or limits of the finished new specification parameter its corresponding test B.II.d.1.d - Change in and/or limits of the finished non-significant specification B.II.d.1.e - Change in and/or limits of the finished outside the approved specifications B.II.e.2.b - Change in and/or limits of the immediate finished product - Addition parameter to the specification test method B.II.f.1.a.1 - Stability life of the finished product B.II.f.1.d - Stability of   |
|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

<div style=\"page-break-after: always\"></div>

<!-- image -->

| diluted/reconstituted product B.II.b.1.a - Replacement manufacturing site for the site B.II.b.1.a - Replacement manufacturing site for the site B.II.b.2.c.1 - Change to arrangements and quality Replacement or addition responsible for importation Not including batch control/testing B.II.b.2.c.1 - Change to arrangements and quality Replacement or addition responsible for importation Not including batch control/testing B.II.d.1.c - Change in the and/or limits of the finished new specification parameter its corresponding test method B.II.d.1.c - Change in the and/or limits of the finished new specification parameter its corresponding test method B.II.d.1.c - Change in the and/or limits of the finished new specification parameter its corresponding test method B.II.d.1.c - Change in the and/or limits of the finished   |
|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

<div style=\"page-break-after: always\"></div>

|           | its corresponding test method B.II.d.2.d - Change in test procedure for the finished product - Other changes to a test procedure (including replacement or addition) B.II.d.2.d - Change in test procedure for the finished product - Other changes to a test procedure (including replacement or addition)                                                                                                                                            |            |     |         |
|-----------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|-----|---------|
| IB/0056/G | This was an application for a group of variations. B.I.b.1.z - Change in the specification parameters and/or limits of an AS, starting material/intermediate/reagent - Other variation B.I.b.2.a - Change in test procedure for AS or starting material/reagent/intermediate - Minor changes to an approved test procedure B.I.b.2.a - Change in test procedure for AS or starting material/reagent/intermediate - Minor to an approved test procedure | 03/10/2014 | n/a | changes |
| IB/0054/G | This was an application for a group of variations. A.7 - Administrative change - Deletion of manufacturing sites B.I.a.1.z - Change in the manufacturer of AS or of a starting material/reagent/intermediate for AS - Other variation B.I.a.2.e - Changes in the manufacturing process of the AS - Minor change to the restricted part of an ASMF B.I.b.1.c - Change in the specification parameters                                                   | 16/09/2014 | n/a |         |

<div style=\"page-break-after: always\"></div>

|         | and/or limits of an AS, starting material/intermediate/reagent - Addition of a new specification parameter to the specification with its corresponding test method B.I.d.1.a.4 - Stability of AS - Change in the re-test period/storage period - Extension or introduction of a re-test period/storage period supported by real time data B.III.2.a.1 - Change of specification(s) of a former non EU Pharmacopoeial substance to fully comply with the Ph. Eur. or with a national pharmacopoeia of a Member State - AS                                                                                                                                                                                                            |            |            |             |
|---------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|-------------|
| IB/0057 | Update of sections 4.4 and 5.1 of the SmPC in order to reflect the level of data available in adolescents with bipolar I disorder (manic or mixed episodes) or schizophrenia following the completion of a long- term safety study, to fulfil the requirement laid down in Article 46 of the paediatric regulation following the same change for the originator. The MAH took also the opportunity to align the Product Information with the QRD template (Version 9). C.I.2.a - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessment of the same change for the reference product - Implementation of change(s) for which NO new additional data is required to be submitted by the MAH | 27/08/2014 | 09/04/2015 | SmPC and PL |

<div style=\"page-break-after: always\"></div>

| IB/0053   | B.II.f.1.b.1 - Stability of FP - Extension of the shelf life of the finished product - As packaged for sale (supported by real time data)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           | 23/09/2013   | 28/02/2014   | SmPC                   |
|-----------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|--------------|------------------------|
| IB/0052   | C.I.2.a - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessment of the same change for the reference product - Implementation of change(s) for which NO new additional data are submitted by the MAH                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      | 22/08/2013   | 28/02/2014   | SmPC, Annex II and PL  |
| IAIN/0051 | C.I.z - Changes (Safety/Efficacy) of Human and Veterinary Medicinal Products - Other variation                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      | 07/05/2013   | n/a          |                        |
| IB/0050/G | This was an application for a group of variations. B.II.e.5.a.2 - Change in pack size of the finished product - Change in the number of units (e.g. tablets, ampoules, etc.) in a pack - Change outside the range of the currently approved pack sizes B.II.e.5.a.2 - Change in pack size of the finished product - Change in the number of units (e.g. tablets, ampoules, etc.) in a pack - Change outside the range of the currently approved pack sizes B.II.e.5.a.2 - Change in pack size of the finished product - Change in the number of units (e.g. tablets, ampoules, etc.) in a pack - Change outside the range of the currently approved pack sizes B.II.e.5.a.2 - Change in pack size of the finished product - Change in the number of units (e.g. tablets, ampoules, etc.) in a pack - Change outside | 01/03/2013   | 28/02/2014   | SmPC, Labelling and PL |

<div style=\"page-break-after: always\"></div>

|        | the range of the currently approved pack sizes B.II.e.5.a.2 - Change in pack size of the finished product - Change in the number of units (e.g. tablets, ampoules, etc.) in a pack - Change outside the range of the currently approved pack sizes B.II.e.5.a.2 - Change in pack size of the finished product - Change in the number of units (e.g. tablets, ampoules, etc.) in a pack - Change outside the range of the currently approved pack sizes B.II.e.5.a.2 - Change in pack size of the finished product - Change in the number of units (e.g. tablets, ampoules, etc.) in a pack - Change outside the range of the currently approved pack sizes B.II.e.5.a.2 - Change in pack size of the finished product - Change in the number of units (e.g. tablets, ampoules, etc.) in a pack - Change outside the range of the currently approved pack sizes B.II.e.5.a.2 - Change in pack size of the finished product - Change in the number of units (e.g. tablets, ampoules, etc.) in a pack - Change outside the range of the currently approved pack sizes B.II.e.5.a.2 - Change in pack size of the finished product - Change in the number of units (e.g. tablets, ampoules, etc.) in a pack - Change outside   |            |            |
|--------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|
| R/0048 | Renewal of the marketing authorisation.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   | 20/09/2012 | 12/11/2012 |

<div style=\"page-break-after: always\"></div>

|             |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |            |            |                                  | considered that the benefit risk profile of Olanzapine Teva continues to be favourable.   |
|-------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|----------------------------------|-------------------------------------------------------------------------------------------|
| IB/0049     | Update of the section 4.8 of the SmPC to add urinary retention as an undesirable effect and to reflect this change in the section 4 of the PLs further to a cumulative review o f 'urinary retention' in temporal association with olanzapine treatment in line with the reference medicinal product. In addition, changes are proposed throughout the product information to bring it in line with version 8 of the QRD template. In addition, contact details for local representatives have been updated. Also, changes in the text for Czech Republic, Germany, Hungary, Norway, Portugal, Italy and Spain were implemented in line with the reference medicinal product. C.I.2.a - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessment of the same change for the reference product - Implementation of change(s) for which NO new additional data are submitted by the MAH | 20/09/2012 | 12/11/2012 | SmPC, Annex II, Labelling and PL |                                                                                           |
| IAIN/0047/G | This was an application for a group of variations. B.II.b.1.a - Replacement or addition of a manufacturing site for the FP - Secondary packaging site B.II.b.1.a - Replacement or addition of a manufacturing site for the FP - Secondary packaging site                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     | 05/07/2012 | n/a        |                                  |                                                                                           |

<div style=\"page-break-after: always\"></div>

| IAIN/0046/G   | This was an application for a group of variations.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 | 25/06/2012   | n/a        |             |                |
|---------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|------------|-------------|----------------|
|               | B.I.a.1.a - Change in the manufacturer of AS or of a starting material/reagent/intermediate for AS - The proposed manufacturer is part of the same pharmaceutical group as the currently approved manufacturer B.I.b.1.b - Change in the specification parameters and/or limits of an AS, starting material/intermediate/reagent - Tightening of specification limits B.I.b.1.b - Change in the specification parameters and/or limits of an AS, starting material/intermediate/reagent - Tightening of specification limits B.I.b.1.c - Change in the specification parameters and/or limits of an AS, starting material/intermediate/reagent - Addition of a new specification parameter to the specification with its corresponding test method B.I.c.3.b - Change in test procedure for the immediate packaging of the AS - Other changes to a |              |            |             | test procedure |
| IB/0045       | B.II.d.1.z - Change in the specification parameters and/or limits of the finished product - Other variation                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        | 19/04/2012   | n/a        |             |                |
| IB/0044       | Following PhVWP/CHMP conclusions of June 2011, update of the Summary of Product Characteristics (SmPC) and Package Leaflet (PL) in line with the reference medicinal product regarding the use of                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  | 13/01/2012   | 08/08/2012 | SmPC and PL |                |

<div style=\"page-break-after: always\"></div>

|             | the third trimester of pregnancy and risk of abnormal muscle movements and/or withdrawal symptoms in newborns in accordance with the PhVWP/CHMP class labelling recommended wording. In addition, contact details for local representatives in Malta and Italy have been updated. A correction related to the product name has been made in the Dutch annex. C.I.2.a - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessment of the same change for the reference product - Implementation of change(s) for which NO new additional data are submitted by the MAH   |            |            |                       | antipsychotics during   |
|-------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|-----------------------|-------------------------|
| IAIN/0043   | A.5.a - Administrative change - Change in the name and/or address of a manufacturer responsible for batch release                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             | 15/12/2011 | 17/02/2012 | SmPC, Annex II and PL |                         |
| IAIN/0042/G | This was an application for a group of variations. B.II.b.2.b.1 - Change to batch release arrangements and quality control testing of the FP - Not including batch control/testing A.7 - Administrative change - Deletion of manufacturing sites                                                                                                                                                                                                                                                                                                                                                              | 10/11/2011 | 17/02/2012 | Annex II and PL       |                         |
| IA/0041/G   | This was an application for a group of variations. B.II.b.1.a - Replacement or addition of a manufacturing site for the FP - Secondary packaging                                                                                                                                                                                                                                                                                                                                                                                                                                                              | 19/08/2011 | n/a        |                       |                         |

<div style=\"page-break-after: always\"></div>

|         | site B.II.b.1.b - Replacement or addition of a manufacturing site for the FP - Primary packaging site                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |            |     |             |
|---------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|-----|-------------|
| IB/0040 | Update of the section 4.4 of the Summary of Product Characteristics (deletion of a sentence in the warning related to hepatic function) and section 4.8 (modification of the prolactin information in the footnote). Additionally, for all EEA languages, linguistic changes were made inline with the reference product information annexes. Furthermore, for EEA languages (EL, IT, PL and SL), minor spelling and grammatical corrections were made. Additionally, for EEA language HU, labelling text was updated to add active substance to Section 1. The product information annexes were also updated according to the QRD templates (version 7.3.1). Local Technical Representative name and contact details in the PIL texts were updated. C.I.2.a - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessment of the same change for the reference product - Implementation of change(s) for which NO new additional data are submitted by the MAH | 12/11/2010 | n/a | SmPC and PL |
| IA/0039 | B.II.d.1.a - Change in the specification parameters and/or limits of the finished product - Tightening of specification limits                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      | 06/08/2010 | n/a | SmPC and PL |

<div style=\"page-break-after: always\"></div>

| IB/0038   | Update of the sections 4.8 and 4.4 of the Summary of Product Characteristics (SPC) in line with the Product Information of the reference product regarding sudden cardiac death, urinary incontinence and information on elevated plasma prolactin concentrations and related clinical manifestations. Section 4 of the package leaflet has also been amended accordingly. Additionally, editorial changes were made in the relevant sections of the Product Information in line with the reference medicinal product. C.I.2.a - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessment of the same change for the reference product - Implementation of change(s) for which NO new additional data are submitted by the MAH   | 31/03/2010   | n/a        | SmPC and PL   |                                                                                                                                                                                                                                                                                                                                                 |
|-----------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|------------|---------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| II/0037   | Update to section 4.8 of the Summary of Product Characteristics (SPC) in line with the Product Information of the reference medicinal products. An editorial change was made in section 4.4 of the SPC. Update of Summary of Product Characteristics                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    | 24/09/2009   | 19/10/2009 | SmPC          | The SPC was updated to align it with that of the reference medicinal products. This followed a change to the SPC of the reference medicinal products via the following procedures: Zyprexa (EMEA/H/C/000115/II/0099) and Zyprexa Velotab (EMEA/H/C/000287/II/0070).                                                                             |
| II/0036   | Update to sections 4.4 and 4.9 of the Summary of Product Characteristics (SPC) in line with the Product Information of the reference medicinal product Zyprexa. Section 5.1 of the SPC was also updated with regard to details of the ATC code.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         | 25/06/2009   | 20/07/2009 | SmPC          | Following changes to the SPC of the reference medicinal product Zyprexa, section 4.4, 4.9 and 5.1 of the Olanzapine Teva SPC were updated. Recommendations on monitoring of patients for signs and symptoms of hyperglycaemia, worsening of glucose control and weight gain were added to section 4.4 and new information on acute overdose was |

<div style=\"page-break-after: always\"></div>

|         | Update of Summary of Product Characteristics                                                                                                                                                                                                                  |            |            |             | added to section 4.9. Section 5.1 of the SPC was also updated with regard to details of the ATC code. The summary of the above mentioned changes may be found in the EPARs (module 8B) of Zyprexa (II/96) and Zyprexa Velotab (II/68).                                                                                                                                                                                                                                                  |
|---------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|-------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| II/0034 | Update of Section 4.8 of the SPC in line with the reference medicinal product. Some minor editorial changes have been introduced to keep the SPC in line with that for the reference product. Update of Summary of Product Characteristics                    | 23/10/2008 | 21/11/2008 | SmPC        | Following a change to the SPC of the reference medicinal product, Section 4.8 of the SPC of Olanzapine Teva were updated to align them with those of the reference medicinal product to include new data regarding changes in bodyweight, glucose and lipid levels over time in adults and adolescents. The summary of the above mentioned changes may be found in the EPARs (module 8B) of Zyprexa (II/92) and Zyprexa Velotab (II/61).                                                |
| IB/0035 | IB_07_c_Replacement/add. of manufacturing site: All other manufacturing operations ex. batch release IA_08_b_02_Change in BR/QC testing - repl./add. manuf. responsible for BR - incl. BC/testing                                                             | 23/09/2008 | n/a        | PL          |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
| II/0032 | Update of Sections 4.2, 4.4, 4.5, 4.8, 5.1 and 5.2 of the SPC in line with the reference medicinal product. The Product Information was updated in accordance with the latest QRD templates. Update of Summary of Product Characteristics and Package Leaflet | 24/07/2008 | 02/09/2008 | SmPC and PL | Following a change to the SPC of the reference medicinal product, Sections 4.2, 4.4, 4.5, 4.8, 5.1 and 5.2 of the SPC of Olanzapine Teva were updated to align them with those of the reference medicinal product to include data from studies conducted in adolescent population with schizophrenia and bipolar I disorder (manic or mixed episodes). The summary of the above mentioned changes may be found in the EPARs (module 8B) of Zyprexa (II/83) and Zyprexa Velotab (II/52). |

<div style=\"page-break-after: always\"></div>

| IB/0033   | IB_30_b_Change in supplier of packaging components - replacement/addition                                                                                                                         | 07/08/2008   | n/a        |                 |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
|-----------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|------------|-----------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| IA/0031   | IA_08_b_01_Change in BR/QC testing - repl./add. manuf. responsible for BR - not incl. BC/testing                                                                                                  | 11/06/2008   | n/a        | Annex II and PL |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
| IA/0030   | IA_08_b_01_Change in BR/QC testing - repl./add. manuf. responsible for BR - not incl. BC/testing                                                                                                  | 11/06/2008   | n/a        | Annex II and PL |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
| II/0024   | Update of section 4.4 and 4.8 of Summary of Product Characteristics and relevant section of the Package Leaflet. Update of Summary of Product Characteristics and Package Leaflet                 | 24/04/2008   | 10/06/2008 | SmPC and PL     | Following a change to the product information of its reference medicinal product, the SPC and PL of Olanzapine Neopharma was updated to align it with it. Both existing warnings on diabetes and lipids alterations in section 4.4 of the SPC have been updated. In addition, section 4.8 of the SPC was amended to add the term \"glycosuria\" as commonly occurring event, to amend the frequency of hyperglycaemia from very rare to rare, and to add further information in relation to weight gain, elevated glucose levels, elevated triglyceride levels and elevated cholesterol levels. The Package Leaflet was amended accordingly. |
| IB/0028   | IB_07_c_Replacement/add. of manufacturing site: All other manufacturing operations ex. batch release IA_08_b_02_Change in BR/QC testing - repl./add. manuf. responsible for BR - incl. BC/testing | 10/06/2008   | n/a        | Annex II and PL |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
| IB/0027   | IB_14_a_Change in manuf. of active substance without Ph. Eur. certificate - change in manuf. site                                                                                                 | 10/06/2008   | n/a        |                 |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |

<div style=\"page-break-after: always\"></div>

|         | IA_32_b_Change in batch size of the finished product - downscaling down to 10-fold                                                                                                | 29/05/2008   | n/a        |                        | IA/0029   |
|---------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|------------|------------------------|-----------|
| N/0001  | Update of the list of local representatives in section 6 of the Package Leaflet. Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification) | 07/03/2008   | n/a        | PL                     |           |
| IB/0023 | IB_42_a_01_Change in shelf-life of finished product - as packaged for sale                                                                                                        | 27/02/2008   | n/a        | SmPC                   |           |
| IB/0021 | IB_41_a_02_Change in pack size - change in no. of units outside range of appr. pack size                                                                                          | 08/02/2008   | 08/02/2008 | SmPC, Labelling and PL |           |
| IB/0020 | IB_41_a_02_Change in pack size - change in no. of units outside range of appr. pack size                                                                                          | 08/02/2008   | 08/02/2008 | SmPC, Labelling and PL |           |
| IB/0019 | IB_41_a_02_Change in pack size - change in no. of units outside range of appr. pack size                                                                                          | 08/02/2008   | 08/02/2008 | SmPC, Labelling and PL |           |
| IB/0018 | IB_41_a_02_Change in pack size - change in no. of units outside range of appr. pack size                                                                                          | 08/02/2008   | 08/02/2008 | SmPC, Labelling and PL |           |
| IB/0017 | IB_41_a_02_Change in pack size - change in no. of units outside range of appr. pack size                                                                                          | 08/02/2008   | 08/02/2008 | SmPC, Labelling and PL |           |
| IB/0016 | IB_41_a_02_Change in pack size - change in no. of units outside range of appr. pack size                                                                                          | 08/02/2008   | 08/02/2008 | SmPC, Labelling and    |           |

<div style=\"page-break-after: always\"></div>

|         |                                                                                          |            |            | PL                     |
|---------|------------------------------------------------------------------------------------------|------------|------------|------------------------|
| IB/0015 | IB_41_a_02_Change in pack size - change in no. of units outside range of appr. pack size | 08/02/2008 | 08/02/2008 | SmPC, Labelling and PL |
| IB/0014 | IB_41_a_02_Change in pack size - change in no. of units outside range of appr. pack size | 08/02/2008 | 08/02/2008 | SmPC, Labelling and PL |
| IB/0013 | IB_41_a_02_Change in pack size - change in no. of units outside range of appr. pack size | 08/02/2008 | 08/02/2008 | SmPC, Labelling and PL |
| IB/0012 | IB_41_a_02_Change in pack size - change in no. of units outside range of appr. pack size | 08/02/2008 | 08/02/2008 | SmPC, Labelling and PL |
| IA/0011 | IA_41_a_01_Change in pack size - change in no. of units within range of appr. pack size  | 29/01/2008 | 29/01/2008 | SmPC, Labelling and PL |
| IA/0010 | IA_41_a_01_Change in pack size - change in no. of units within range of appr. pack size  | 29/01/2008 | 29/01/2008 | SmPC, Labelling and PL |
| IA/0009 | IA_41_a_01_Change in pack size - change in no. of units within range of appr. pack size  | 29/01/2008 | 29/01/2008 | SmPC, Labelling and PL |
| IA/0008 | IA_41_a_01_Change in pack size - change in no. of units within range of appr. pack size  | 29/01/2008 | 29/01/2008 | SmPC, Labelling and PL |
| IA/0007 | IA_41_a_01_Change in pack size - change in no. of units within range of appr. pack size  | 29/01/2008 | 29/01/2008 | SmPC, Labelling and    |

<div style=\"page-break-after: always\"></div>

|         |                                                                                         |            |            | PL                     |
|---------|-----------------------------------------------------------------------------------------|------------|------------|------------------------|
| IA/0006 | IA_41_a_01_Change in pack size - change in no. of units within range of appr. pack size | 29/01/2008 | 29/01/2008 | SmPC, Labelling and PL |
| IA/0005 | IA_41_a_01_Change in pack size - change in no. of units within range of appr. pack size | 29/01/2008 | 29/01/2008 | SmPC, Labelling and PL |
| IA/0004 | IA_41_a_01_Change in pack size - change in no. of units within range of appr. pack size | 29/01/2008 | 29/01/2008 | SmPC, Labelling and PL |
| IA/0003 | IA_41_a_01_Change in pack size - change in no. of units within range of appr. pack size | 29/01/2008 | 29/01/2008 | SmPC, Labelling and PL |
| IA/0002 | IA_41_a_01_Change in pack size - change in no. of units within range of appr. pack size | 29/01/2008 | 29/01/2008 | SmPC, Labelling and PL |